Anti-BTEB3 antibody
Specifications
| Product Cat#: | AB-06-4945 |
| Product type: | Primary antibody |
| Antigen: | BTEB3 |
| Immunogen: | The antiserum was produced against synthesized peptide derived from human KLF13 around the non-acetylation site of Lys166. AA range: 131-180. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400-1:2000); Immunohistochemistry-Paraffin (1:100-300) |
| Reactivity: | Human, Mouse |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 1*PBS buffer (pH7.4), 0.5% BSA, 50% Glycerol, 0.02% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Immunogen affinity purified. |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Conjugate: | Unconjugated |
| Alternative names: | KLF13 antibody; BTEB3 antibody; NSLP1 antibody; Krueppel-like factor 13 antibody; Basic transcription element-binding protein 3 antibody; BTE-binding protein 3 antibody; Novel Sp1-like zinc finger transcription factor 1 antibody;RANTES factor of late activated T-lymphocytes 1 antibody; RFLAT-1 antibody; Transcription factor BTEB3 antibody; Transcription factor NSLP1 antibody |
Show More
Target information
Represses transcription by binding to the BTE site, a GC-rich DNA element, in competition with the activator SP1. It also represses transcription by interacting with the corepressor Sin3A and HDAC1. Activates RANTES expression in T-cells.
Provider
Erpantech Laboratory
